Amphista Therapeutics

Cambridge, United Kingdom

Amphista Therapeutics operates as a biopharmaceutical company.

Dec 2022

Series B

Top Investors

Dementia Discovery Fund Forbion Capital Partners European Investment Fund Gilde Healthcare Eli Lilly & Company Foundation

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Amphista Therapeutics

Who are Amphista Therapeutics's investors?

Amphista Therapeutics's investors include Dementia Discovery Fund, Forbion Capital Partners, European Investment Fund, Gilde Healthcare, Eli Lilly & Company Foundation.

Where is Amphista Therapeutics headquartered?

Amphista Therapeutics is headquartered in Cambridge, United Kingdom.

What does Amphista Therapeutics do?

Amphista Therapeutics operates as a biopharmaceutical company.

What stage is Amphista Therapeutics at?

Amphista Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 13, 2022.

MLA

"Amphista Therapeutics — Funding & Investors." VCBacked, December 13, 2022, https://www.vcbacked.co/company/amphista-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2022). Amphista Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/amphista-therapeutics

Wikipedia (cite web)

{{cite web |title=Amphista Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/amphista-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 13, 2022.